Vanda Pharmaceuticals Inc. · Brief

Next report

102 days

Feb 10 · after closeest.Q4 FY26

Expected move

No implied move.

8 reportsHistory

4 of 8≥ implied

Feb 13 '25±8.5%▼−5.96%×0.70

May 7 '25±10.1%▼−3.65%×0.36

Jul 31 '25±8.5%▼−8.78%×1.03

Q3 FY25±14.4%▼−20.15%×1.40

Feb 11 '26±11.0%▼−17.63%×1.60

Q1 FY26±13.3%▼−14.11%×1.06

Q2 FY26±18.7%▲+0.49%×0.03

Q3 FY26±11.7%▲+1.25%×0.11

quarterimplied−25%0+25%realized×

Q3 FY26±11.7%▲+1.25%×0.11

Q2 FY26±18.7%▲+0.49%×0.03

Q1 FY26±13.3%▼−14.11%×1.06

Feb '26±11.0%▼−17.63%×1.60

Q3 FY25±14.4%▼−20.15%×1.40

Jul '25±8.5%▼−8.78%×1.03

2 older reports

May '25±10.1%▼−3.65%×0.36

Feb '25±8.5%▼−5.96%×0.70

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Feb 10 report · est.

—

VNDA report session

No linked exposure.

Oct 21report dateEarnings date confirmed: Oct 28, after close.Source

Oct 14impliedImplied move: ±22.7% into Oct 28 earnings (Oct 14 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.